Atherosclerotic Cardiovascular Disease

The initial 90‐day window after ACS represents a vulnerable period for recurrent events, possibly attributable to atherothrombosis mechanisms not currently addressed with optimal therapy, researchers reported.

Sodium-glucose cotransporter 2 inhibitors are an effective class of drugs for improving morbidity and mortality in patients with established atherosclerotic CVD or cardiovascular risk factors, researchers reported.

Among patients with premature atherosclerotic CVD, women were more likely to report poor mental and physical health than men, according to data published in JAMA Cardiology.

In last week’s top story in cardiology, a cross-sectional analysis found that cannabis use was significantly associated with increased odds of having a high atherosclerotic CVD risk.

Elevated atherosclerotic CVD risk was linked to cannabis use in a study published in the American Journal of Cardiology.

Last week’s top story in cardiology was about the FDA approval of Leqvio for LDL lowering. According to the manufacturer, the drug is administered twice a year after the initial dose and a follow-up dose at 3 months.

Aspirin use for primary atherosclerotic CVD prevention continues to be prevalent in adults aged 70 years or older despite contrary guideline recommendations, according to data published in the American Journal of Preventive Cardiology.

A retrospective analysis published in JAMA Cardiology found significant improvement in atherosclerotic CVD risk prediction among participants with former smoking, pack-years and years since quitting.

Infertility was independently associated with an increased risk for atherosclerotic CVD among nulliparous women, a longitudinal cohort study showed.

CV events with degarelix (Firmagon, Ferring Pharmaceuticals) or leuprolide in patients with advanced prostate cancer and CVD.